Demystifying Immunosuppression: A Systematic Workflow for Analyzing Regulatory T Cells (Tregs) in the Tumor Microenvironment
The advent of cancer immunotherapy has fundamentally shifted the paradigm of oncology. Treatments such as immune checkpoint inhibitors and CAR-T cell therapies have yielded unprecedented clinical responses. However, a significant portion of patients still experience primary or acquired resistance. Today, researchers agree that the major culprit behind this resistance is the highly complex,...
0 Comentários 0 Compartilhamentos 6 Visualizações 0 Anterior